Teledermatology mobile apps: Implementation and impact on Veterans' access to dermatology
远程皮肤科移动应用程序:实施及其对退伍军人获得皮肤科的影响
基本信息
- 批准号:9981444
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-01-01 至 2021-09-30
- 项目状态:已结题
- 来源:
- 关键词:AchievementAddressAdoptedAdoptionAffectAppointmentCaringCharacteristicsClinicClinicalCluster randomized trialCodeCollaborationsConsultConsultationsControl GroupsDataDermatologicDermatologistDermatologyDocumentationEffectivenessEvaluationFutureGeographyHealthHealthcare SystemsInterventionInterviewLeadershipLinkMeasuresMonitorOutcomeOutcome MeasurePatientsPersonsPoliciesPrimary Health CareProcessProviderRandomizedReadinessResearchResearch Project GrantsResourcesRuralServicesSiteSkinSkin CareSpeedStructureSurveysTelemedicineTestingTimeTravelVeteransVisitWorkbasecare providerscomparison interventioncostdata warehousedesignevidence basefollow-upformative assessmenthandheld mobile devicehealth administrationhealth care availabilityhealth care service organizationimagerimplementation strategyimprovedinnovationinterestmobile applicationnoveloperationprimary outcomeprogramsremote health careruralityskin disordertelehealththeoriestreatment as usualtreatment responsetrial designuptake
项目摘要
Teledermatology has emerged as an effective option to enhance the access of patients to high quality skin
care in VA. VA's Office of Connected Care has developed two innovative mobile apps for VA teledermatology.
One app, VA Telederm, streamlines the current workstation-based consultative process between primary care
providers, teledermatology imagers and dermatologists, and is intended to lower the threshold for utilizing
teledermatology in VA primary care clinics. The other app, My Telederm, will allow established dermatology
patients to follow-up with VA dermatologists remotely rather than using in-person, clinic-based appointments.
The app is intended to reduce the distances that appropriate established patients must travel to dermatology
clinics and to improve the reliability of follow-up. It is also anticipated to free up appointment slots for new and
established patients who actually must be seen in-person. The proposed research will test the hypothesis
that successful implementation of each app will facilitate access of Veterans to dermatologic care. Each
mobile app and its associated technical and clinical support resources will be rolled out in a stepped wedge
cluster randomized trial design involving sites that are most likely to benefit from their use. The proposed
research will compare outcomes for sites that have received the app to those that have not yet received it.
Aim 1 will explicitly test the hypothesis by examining the following primary outcomes for both apps: 1)
Measures of temporal access will be assessed by comparing intervention and control groups with respect to all
dermatology consult and appointment completion times; 2) Measures of geographic access will include travel
distance and rurality; 3) Measures of total access will be reflected in the total instances of care as reflected by
the total numbers of dermatology/teledermatology encounters. In addition, outcome measures for the My
Telederm app will also include timeliness of follow-up with respect to the target date, and the no-show rate,
and the proportion of new patients in conventional dermatology clinics. Results will also be stratified by
rurality. Aim 2 will examine the factors that affect successful implementation and impact of each app. Guided
by the Replicating Effective Programs framework and Weiner's Organizational Theory of Implementation
Effectiveness, we will conduct in-depth formative evaluations at 3 early adopter sites for each app to determine
organizational, leadership, and end-user characteristics that correlate with implementation of the apps. In
addition, using nationally and remotely available enterprise-wide data, we will measure implementation and
adoption of apps at all participating sites. At the end of the study period, the proposed research will result in a
novel documentation of mobile teledermatology's effectiveness in enhancing Veterans' access to dermatology
services, as well as produce a comprehensive understanding of the factors leading to successful mobile
telehealth implementation. The results will be of significance to VA as it develops and implements other mobile
telehealth programs, and more generally to other healthcare organizations planning for large-scale telehealth
interventions.
远程皮肤病学已成为一种有效的选择,以提高获得高质量的皮肤的病人
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Implementation of Direct-to-Patient Mobile Teledermatology in VA.
在弗吉尼亚州实施直接面向患者的移动远程皮肤科。
- DOI:10.1007/s11606-023-08480-1
- 发表时间:2024
- 期刊:
- 影响因子:5.7
- 作者:Peracca,SaraB;Lachica,Olevie;Lamkin,RebeccaP;Jackson,GeorgeL;Mohr,DavidC;King,HeatherA;Whited,JohnD;Fonseca,AlleneS;Morris,IsisJ;Gifford,AllenL;Weinstock,MartinA;Oh,DennisH
- 通讯作者:Oh,DennisH
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DENNIS H OH其他文献
DENNIS H OH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DENNIS H OH', 18)}}的其他基金
Improving dermatology access by direct-to-patient teledermatology and computer-assisted diagnosis
通过直接面向患者的远程皮肤病学和计算机辅助诊断改善皮肤病学的可及性
- 批准号:
10317682 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Improving dermatology access by direct-to-patient teledermatology and computer-assisted diagnosis
通过直接面向患者的远程皮肤病学和计算机辅助诊断改善皮肤病学的可及性
- 批准号:
10496557 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Role of p53 homologs in DNA repair in human keratinocytes
p53 同源物在人类角质形成细胞 DNA 修复中的作用
- 批准号:
7797798 - 财政年份:2009
- 资助金额:
-- - 项目类别:
Role of p53 homologs in DNA repair in human keratinocytes
p53 同源物在人类角质形成细胞 DNA 修复中的作用
- 批准号:
7911825 - 财政年份:2009
- 资助金额:
-- - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
-- - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
-- - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant














{{item.name}}会员




